Cardene Structural Formula (Image 01)
Cardene Iv Injection, Solution
Product Images NDC 43066-026
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cardene Iv (NDC 43066-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Representative 20 mg Container Lbl Panel 1 Of 2 (Image 02)
This is a description of a medical solution of Nicardipine Hydrochloride for intravenous use. The solution is contained in a single-use container coded 263447 and has a concentration of 0.1 mg/mL. It is made up of 0.1 mg Nicardipine Hydrochloride in 86 mg Sodium Chloride USP with additional components such as Citric Acid Anhydrous USP and Sorbitol NF. Hydrochloric Acid and/or Sodium Hydroxide may have been added to adjust pH. The dosage information is not available, but physicians should see the prescribing information. The solution should be checked for leaks and not used if it is not clear. The solution is not to be used in series connection and should be stored at a controlled room temperature of 20-25°C. The manufacturers of the solution are Barter Healthcare Corporation, and contact information is provided for reporting any adverse reactions.*
Representative 20 mg Container Lbl Panel 2 Of 2 (Image 03)
Representative 20 mg Carton Lbl (Image 04)
Representative Serialization 43066-026-10 (Image 05)
CARDENE’LV is a medication that contains Nicardipine Hydrochloride of 40mg in 200mL of 0.83% sodium chloride injection. It is used for intravenous use and each mL contains 0.2mg of Nicardipine Hydrochloride. It is advised not to add any additional medication and it must not be used in series connections. The solution should be checked for any minute leaks before use. CARDENE’LV is a registered trademark of Chies USA, Inc. The medication can be stored at controlled room temperate and must be protected from light and freezing. In case of suspected adverse reactions, contact Baxter Healthcare Corporation.*
Representative 40 mg Container Panel 1 Of 2 (Image 06)
Representative 40 mg Container Panel 2 Of 2 (Image 07)
This text is providing details about Nicardipine Hydrochloride drug available in CARDENE'I.V. form, which is an injection to treat high blood pressure. The drug comes in a 40 mg dose in 200 mL of 0.83% Sodium Chloride Injection. The concentration of Nicardipine Hydrochloride is 0.2 mg/mL that needs to be carefully checked during infusion. The information instructs users to discard any unused portion of the subject drug. The drug must be stored in its carton until it is ready to use. The text also provides instructions and warnings for users, such as keeping the drug at room temperature (20-25°C) and not using it after the expiration date. Finally, this text lists the manufacturer's name, patent numbers, product code, etc.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
